Home » Topics » Regulatory » Patents

Patents
RSS

Researchers at Lilly describe novel cannabinoid CB2 receptor agonists

Nov. 4, 2011

Novel casein kinase II inhibitors reported by BMS

Nov. 4, 2011

Korean company patents new glucagon GLP-1 receptor agonists

Nov. 4, 2011

Tetraphase Pharmaceuticals synthesizes new antibacterial agents

Nov. 4, 2011

Tibotec presents novel HIV integrase inhibitors

Nov. 4, 2011

Life Sciences Research Partners and Flanders' VIB claim new cell-based ischemia therapy

Nov. 4, 2011

RespiVert prepares novel MAP kinase p38 inhibitors

Nov. 4, 2011

New mTOR inhibitors disclosed by Auspex Pharmaceuticals

Nov. 4, 2011

Novel receptor-interacting protein 2 inhibitors prepared by GSK

Nov. 3, 2011

Array BioPharma and Genentech jointly synthesize new beta-secretase 1 inhibitors

Nov. 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...